Helius Medical Technologies Inc. held a special meeting of stockholders on May 23, 2025. The stockholders approved several proposals, including a reverse stock split, an increase in the number of authorized shares of common stock to up to 800,000,000 shares, and the issuance of up to 148,621,326 shares of common stock in a potential financing. Additionally, an amendment to the 2022 Equity Incentive Plan was approved, as well as the authorization to adjourn the meeting to solicit additional proxies if needed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.